MOLECUBES: Bruker Announces Acquisition of MOLECUBES NV
Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of MOLECUBES NV , a dynamic innovator in benchtop preclinical nuclear molecular imaging (NMI) systems.
Read full article »
MOLECUBES is a Belgium-based biotechnology company that designs and manufactures preclinical imaging PET, SPECT and CT CUBES systems for the laboratory industry.
Read more